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Background: Berlinia grandiflora is a tropical pant which grows in most countries of West and Central Africa.  Its 
bark sap, stem bark and leaves are used locally by the Igbos of South Eastern Nigeria to treat various health conditions 
including microbial infections. 
Objective: The objectives of our study was to investigate the antimicrobial potentials of its aqueous, methanol and 
butanol stem bark and leaves extracts against eight pathogenic bacteria.  
Methodology: The effects of various concentrations of the extracts were determined against the pathogenic bacteria 
and the minimum inhibitory concentrations (MICs) were established using standard methods.  The MIC evaluations 
established the susceptibility of the bacteria to the extracts and the zones of inhibition assays quantified the 
antibacterial activities of the extracts. Similar studies with ciprofloxacin hydrochloride as reference drug were 
undertaken. 
Results: The results indicate that the phytochemical extracts of the plant parts possess appreciable antibacterial 
activity against selected species of pathogenic bacteria. Staphylococcus aureus showed the highest sensitivity to the 
extracts with the lowest MIC of 21 mg/ml and the largest zone of inhibition of 28.0 ± 0.01 mm with the methanol stem 
bark extract and 41.0 ± 0.11 mm for ciprofloxacin hydrochloride. Serratia marcescens had the highest MIC (140 
mg/ml) with the butanol stem bark extract. The methanol stem bark and leaves extracts showed similar antibacterial 
activity against the isolates with MIC ranging from 50 mg/ml for most bacteria and 75 mg/ml for a few. The zones of 
inhibition ranged from 18.0 ± 0.10 mm to 28.0 ± 0.1 mm for the extracts and 12.0 ± 0.02 mm to 41.0 ± 0.11 mm for 
ciprofloxacin hydrochloride. The extracts exhibited appreciable antibacterial activity in the zones of inhibition assay 
against the pathogenic bacteria.  
Conclusion: The study has shown that the phytochemical extracts of the plant parts have antibacterial activity against 
the pathogenic bacteria and has partially validated its ethnomedicinal use. 
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1. Introduction 
Berlinia comprises about 20 species which are confined 
to tropical Africa with almost all the species found in 
West and Central Africa (Hutchison and Dalziel, 1963).    
Berlinia grandiflora is widespread in Guinea, Mali, 
Nigeria, Central Africa and Democratic Republic of 
Congo (Hutchison and Dalziel, 1963). It is a forest tree 
that is sometimes planted as ornamental tree and shade 
tree in villages and coffee plantations.  It is occasionally 
browsed by livestock especially sheep and goats. The 
Igbos of South Eastern Nigeria refers to it in their local 
languages as abaa, dokar, rafi, and ububa while the 
Yorubas of the South West Nigeria refer to it as apado.   
Its bark sap is applied to sores and wounds, and bark 
decoctions are administered to treat haemorrhoids and 
liver complaints (Gill, 1992).  The bark is used to ease 
labour during child birth and gastrointestinal disorders.  
A decoction of the leafy twigs is used as febrifuge and 
antiemetic while leafy decoctions are taken as tonic 
(Gill, 1992). Reports of its biological activities are scanty 
and include analgesic activity of stem bark extract 
(Asuzu et al, 1993), antihelminthic activity of stem bark 
(Enwerem et al, 2001), antihelminthic activity of stem 
bark and its active principle, betulinic acid (Enwerem et 
al, 2001).  
In South Eastern Nigeria, the leaf and the stem bark 
extracts of the plant are used by traditional herbalists to 
treat microbial infections. However, this ethnomedicinal 
use of the plant parts has not been validated 
scientifically. This study investigated the antimicrobial 
potential of the aqueous, methanol and butanol extracts 
of the leaves and stem bark against pathogenic bacteria 
as part of our evaluation of its antimicrobial activity. 
2. Materials and Methods 
2.1 Drugs and chemicals 
Ciprofloxacin hydrochloride used as the standard drug 
in the study was in safe conditions for use while the 
chemicals and solvents were of analytical grade. 
Ciprofloxacin hydrochloride, nutrient agar and nutrient 
broth were products of Sigma Aldrich 
Laborchemikallien, GmBH, Germany, butanol, Meck, 
Germany and methanol, (Scharlau Chemie S.A. Spain). 
2.2 Clinical bacterial isolates 
Eight pathogenic bacteria were used. These included 
Staphylococcus aureus, Escherichia Coli, Alcaligenes 
faecalis, Pseudomonas aeruginosa, Serratia marcescens, 
Enterobacter aerogenes, Proteus vulgaris and Klebseilla 
pneumoniae. They were obtained from the University of 
Benin Teaching Hospital Medical Microbiology 
Laboratory stock Unit. They had been isolated from 
samples of patients for clinical diagnosis of their 
infections. They were authenticated using standard 
morphological and biochemical assays (Cheesbrough, 
2004) in the Department of Pharmaceutical 
Microbiology, Faculty of Pharmacy, University of Benin. 
2.3 Plant materials 
The fresh stem bark and leaves of the plant were 
collected in July, 2011 from a mature tree in Uli village, 
Ihiala Local Government Area, Anambra State, Nigeria.  
The preliminary identification was in the Department of 
Pharmacognosy, Faculty of Pharmacy, University of 
Benin. Identification and authentication was done at the 
Forestry Research Institute of Nigeria (FRIN), where a 
voucher specimen of the plant is deposited (Voucher 
Specimen no: FHI 108436). 
2.4. Extraction of plant materials 
The stem bark was carefully separated from the woody 
part, cut into small bits, shade dried and pulverized 
using a grinder (Lab. Mill serial NO. 4745, Christy and 
Norris Ltd, England) and stored in dry airtight glass jar.   
The leaves were shade dried, pulverized and stored in 
dry airtight glass jar and labelled accordingly.  Each of 
the powdered plant materials (500 g) were macerated 
separately in 98% methanol (2 L) and butanol (2 L) in 
glass jars for 72 hours and were shaken intermittently 
throughout the period. The extracts were filtered 
separately. Another portion of each of the plant 
materials (500 g) were macerated separately in distilled 
water (2 L) for 24 hours and were shaken 
intermittently. The extracts were filtered separately.  
Each of the methanol filtrates and butanol were 
evaporated to dryness at reduced pressure using a 
rotary evaporator to obtain a dark brown residue (stem 
bark) and dark greenish residue (leaves) until a 
constant weight was obtained and the yield with 
reference to the powdered material in each case noted.  
Each of the aqueous filtrates was evaporated to dryness 
in an hot air oven set at 40 °C to obtain a dark brown 
residue (stem bark) and dark greenish residue (leaf) 
until a constant weight was obtained and the yield with 
reference to the powdered material in each case noted. 
The extracts obtained were stored in the refrigerator 
set at a temperature of –4 °C until when required for 
experiments reported in our study. 
2.5. Antibacterial assay 
Determination of the effects of various 
concentrations and minimum inhibitory 
concentrations (MICs) of the plant extracts against 
the pathogenic bacteria 
The agar dilution method described by George and 
Robert (1996) was used to determine the effects of 
various concentrations of the extracts on the pathogenic 
bacteria in order to establish the minimum inhibitory 
concentrations (MICs) of the extracts. The minimum 
inhibitory concentrations of the extracts of stem bark 
and leaves were evaluated using different final 
concentrations in nutrient agar against Staphy. aureus, 
E. Coli, A. faecalis, P. aeruginosa, S. marcescens, E. 
aerogenes, P. vulgaris and K. pneumoniae.  For the 
aqueous stem bark and leaf extracts the concentrations 
were as shown in Table 1 and 2, respectively 
(Supporting Information).  The concentrations for the 
butanol stem bark extract and leaves extract 
concentrations were as shown in Table 3 and 4, 
respectively (Supporting Information). For the 
methanol stem bark and leaves extracts, the 
concentrations used were as shown in Table 5 and 6, 
respectively (Supporting Information).  
Each concentration of the extracts was in triplicate 
plates. Each plate was inoculated with 0.1 ml (106 
CFU/ml) of overnight nutrient broth culture of each of 
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the clinical bacterial isolates. The inoculums were 
spread uniformly on the surface of the agar with the aid 
of a sterile glass spreading rod. The plates were 
incubated at 37 °C and observed for growth after 24 
hours.  The lowest concentration of each extract which 
inhibited the growth of each pathogenic bacterium was 
considered as the MIC for the bacterium. 
Determination of the effect of various 
concentrations of ciprofloxacin hydrochloride and 
minimum inhibitory concentration (MIC) against 
the pathogenic bacteria 
The agar dilution method described by George and 
Robert, (1996) was used to determine the effects of 
various concentrations of ciprofloxacin hydrochloride 
on the pathogenic bacteria in order to establish the 
minimum inhibitory concentrations (MICs) of 
ciprofloxacin hydrochloride.   
The MICs of ciprofloxacin hydrochloride against Staph. 
aureus, E. Coli, A. faecalis, P. aeruginosa, S. marcescens, E. 
aerogenes, P. vulgaris and K. pneumoniae were 
determined in triplicates using final concentrations of 5, 
7.5, 10, 15, 20 and 30 mg/ml  of ciprofloxacin 
hydrochloride in nutrient agar. Each plate was 
inoculated with 0.1 ml of 106 CFU/ml of overnight 
nutrient broth culture of each of the clinical bacterial 
isolates.  The inoculums were spread uniformly on the 
surface of the agar with the aid of a sterile glass 
spreading rod.  The plates were incubated at 37 °C and 
observed for growth after 24 hours.   The lowest 
concentration of ciprofloxacin which inhibited the 
growth of each pathogenic bacterium was considered as 
the MIC for the bacterium. 
Evaluation of antibacterial activity of aqueous, 
butanol and methanol extracts of stem bark and 
leaves of Berlinia grandiflora using zones of 
inhibition 
The agar well diffusion method as described by Perez et 
al (1990) was used.  The antibacterial activity of the 
aqueous, butanol and methanol extracts of Berlinia 
grandiflora was evaluated using Staph. aureus, E. Coli, A. 
faecalis, P. aeruginosa, S. marcescens, E. aerogenes, P. 
vulgaris and K. pneumoniae. The MIC against each 
bacterium exhibited by each extract was used in the 
zone of inhibition experiments. Petri dishes in 
triplicates were labelled with each of the eight clinical 
bacterial isolates and 25 ml of nutrient agar pipetted 
into them aseptically.  The nutrient agar was allowed to 
set and was inoculated with 0.1 ml (106 CFU/ml) of an 
overnight culture of each of the clinical isolates, in 
separate petri dishes. The inoculums were spread 
uniformly on the surface of the agar with the aid of a 
sterile glass spreading rod. Using a sterile cork borer, 
wells of 6 mm in diameter were made in the nutrient 
agar of each plate and labelled accordingly with the 
extract type and ciprofloxacin hydrochloride, to which 
the bacterial isolates were sensitive. The standard drug, 
ciprofloxacin hydrochloride (0.2 ml equivalent to 20 µg) 
of each of its MIC against each bacterium was 
aseptically pipetted into the well at the center while 0.2 
ml of each of the minimum inhibitory concentrations of 
the extracts tested was aseptically pipetted into the 
appropriately labelled well. The plates were left for 10 
minutes on the bench top for the drug and extracts to 
diffuse into the agar. The plates were incubated at 37 °C 
for 24 hours and examined for zones of inhibition 
around the wells. The zones of inhibition were 
measured and recorded. The mean and standard error 
of mean (Mean ± SEM) was determined for the triplicate 
plates in each case. 
3. Results  
The maceration of 500 g of the powdered leaves in 
distilled water, butanol and methanol yielded 35 g 
(7.0%), 20 g (4.0%) and 25 g (5.0%) respectively, while 
the powdered stem bark yield 40 g (8.0%), 22 g (4.4%) 
and 25 g (5.0%) respectively. The results of the effects 
of various concentrations of the aqueous, methanol and 
butanol extracts of leaves and stem bark of Berlinia 
grandiflora are presented in Table 1 – 6 (Supporting 
Information). The results indicate that the extracts 
inhibited the growth of the pathogenic bacteria at 
different concentrations suggesting that the clinical 
bacterial isolates have different sensitivity patterns to 
the extracts.  Table 7 (Supporting Information) shows 
the effects of various concentrations of ciprofloxacin 
hydrochloride against the pathogenic bacteria. The 
results indicate that the clinical bacterial isolates 
showed different sensitivity patterns to ciprofloxacin 
hydrochloride with Proteus vulgaris being the most 
susceptible to ciprofloxacin.  
The minimum inhibitory concentrations (MICs) values 
of ciprofloxacin hydrochloride and the aqueous, 
methanol and butanol extracts of Berlinia grandiflora 
are presented in Table 8.  
The result of the zones of inhibition of the extracts and 
ciprofloxacin against each pathogenic bacterium is 
presented in Table 9.   The zones of inhibition ranged 
from 18.0 ± 0.10 mm to 28.0 ± 0.01mm for the extracts 
and that of the reference drug, ciprofloxacin ranged 
from 12.0 ± 0.02 mm to 37.0 ± 0.14 mm. The methanol 
stem bark extract produced the largest zone of 
inhibition (28.0 ± 0.01 mm) against Staph. aureus.  
Generally the extracts exhibited appreciable 
antibacterial activity in the zones of inhibition assay 
against the pathogenic bacteria. Staph. aureus showed 
the largest zones of inhibition both for the extracts and 
ciprofloxacin while A. faecalis showed the smallest zone 
of inhibition for most of the extracts and ciprofloxacin. 
4. Discussion 
The use of medicinal plants remains the mainstay in 
health care delivery system in most developing 
countries.  Many infectious diseases have been known 
to be treated with herbal remedies throughout the 
history of mankind. The use of medicinal plants to treat 
infectious diseases is on the increase now orchestrated 
by the unavailability, unaffordability of the existing 
antimicrobial agents, coupled with emergence of 
multidrug resistant pathogens that hamper clinical 
efficacy of existing antibiotics (Davis, 1994; Lamikanra 
and Ndep, 1993). Many rural dwellers are now 
reinforcing their use for medicinal plants to treat 
microbial infections. This documents the need for 
scientific research to validate the ethnomedicinal uses 
of these plants and provide leads for new antimicrobial 
agents.   
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Table 8: Minimum inhibition concentrations (MICs) values of aqueous, methanol and butanol extracts of Berlinia 
grandiflora and ciprofloxacin hydrochloride against the pathogenic bacteria 
Pathogenic Bacteria 
Minimum  inhibitory concentration  values (mg/ml) 
Aqueous Extracts Butanol Extracts Methanol Extracts Ciprofloxacin 
(µg/ml) Bark Leaves Bark Leaves Bark Leaves 
Staphylococcus aureus 21.0 21.0 22.0 55.0 55.0 55.0 10.0 
Escherichia coli 24.0 23.0 100.0 50.0 50.0 50.0 25.0 
Alcaligenes faecalis 50.0 47.5 100.0 75.0 75.0 75.0 30.0 
Serratia marcescens 75.0 35.0 140.0 55.0 55.0 55.0 30.0 
Enterobacter aerogenes 90.0 90.0 95.0 55.0 55.0 55.0 30.0 
Klebsiella pneumoniae 75.0 75.0 75.0 50.0 50.0 50.0 30.0 
Pseudomonas aeruginosa 70.0 23.0 23.0 50.0 50.0 50.0 25.0 
Proteus vulgaris 47.5 23.0 23.0 50.0 50.0 50.0 7.5 
 
Table 9: Zones of inhibition of various MICs of extracts of Berlinia grandiflora and ciprofloxacin hydrochloride against 
the pathogenic bacteria 
Pathogenic 
Bacteria 
Zones of Inhibition (mm) 
Aqueous Extracts Butanol Extracts Methanol Extracts 
Ciprofloxacin 
Bark Leaves Bark Leaves Bark Leaves 
Staphylococcus 
aureus 
21.0 ±0.03 27.0 ±0.0.12 27,0 ±0.04 18.0 ±0.02 28.0 ±0.01 27.0 ±0.08 27.0 ±0.04 
Escherichia coli 18.0 ±0.10 19.0 ±0.22 23.0 ±0.21 23.0 ±0.0.13 19.5 + 0.08 27.0 + 0.20 18.0 + 0.20 
Alcaligenes 
faecalis 
19.0 ±0.30 19.0 ±0.24 19.0 ±0.18 19.0 ±0.11 19.5 ±0.19 19.0 ±0.30 22.0 ±0.21 
Serratia 
marcescens 
23.0 ±0.11 20.0 ±0.10 18.0 ±0.0.11 19.0 ±0.03 19.5 ±0.13 18.0 ±0.34 41.0 ±0.11 
Enterobacter 
aerogenes 
24.0 ±0.02 19.0 ±0.23 23.0 ±0.0.14 18.0 ±0.22 25.0 ±0.04 25.0 ±0.26 19.0 ±0.30 
Klebsiella 
pneumoniae 
19.0 ±0.07 19.0 ±0.03 19.0 ±0.60 23.0 ±0.40 19.0 ±0.20 19.0 ±0.18 16.5 ±0.22 
Pseudomonas 
aeruginosa 
22.0 ±0.14 21.0 ±0.21 18.0 ±0.33 20.0 ±0.44 23.0 ±0.11 21.0 ±0.09 12.0 ±0.02 
Proteus 
vulgaris 
23.0 ±0.02 25.0 ±0.22 22.0 ±00.15 18.0 ±0.50 24.0 ±0.09 24.0 ±0.11 37.0 ±0.14 
 
Our study investigated the antibacterial potentials of 
the aqueous, methanol and butanol extracts of stem 
bark and leaves of Berlinia grandiflora against eight 
pathogenic bacteria.  The crude extracts inhibited the 
growth of Staph. aureus, E. coli,  P. aeruginosa and P. 
vulgaris  which have been reported to have multidrug 
resistance at MIC ranging from 21 mg/l to 23 mg/ml 
(Onanuga et al, 2005).  Our study revealed that Staph. 
aureus was the most sensitive pathogenic bacteria to 
the extracts. E. aerogenes and K. pneumoniae were the 
least susceptible to the extracts. Berlinia grandiflora 
extracts inhibited them at MICS of 90 mg/ml and 70 
mg/ml. The methanol stem bark extract produced the 
largest zone of inhibition against Staph. aureus 
indicating its high sensitivity.  
Betulinic acid is a triterpene of natural origin and has 
been isolated from the methanol, hexane and ethyl 
acetate extracts of stem bark of Berlinia grandiflora 
(Enwerem et al, 2001). Betulinic acid and its derivatives 
have been reported to exhibit antimicrobial activity 
(Perumal and  Sriram, 2005).  The antimicrobial activity 
exhibited by the stem bark and leaves extracts of 
Berlinia grandiflora in this study could be ascribed to 
betulinic acid. Generally, the extracts exhibited 
appreciable antibacterial activity in the zones of 
inhibition assay against the pathogenic bacteria. 
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5. Conclusion   
The study has shown that aqueous, methanol and 
butanol extracts of the stem bark and leaves of Berlinia 
grandiflora have antibacterial activity against the 
clinical pathogenic bacteria and could be beneficial in 
the treatment of various bacterial infections caused by 
the organisms used in our study. 
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Table 1: The effects of various concentrations of aqueous leaves extract of Berlinia grandiflora against the pathogenic bacteria 
Pathogenic bacteria 
Final concentrations of aqueous leaf extract in nutrient agar (mg/ml) 
15 20 21 22 23 24 25 30 35 40 45 47.5 50 55 60 65 70 75 80 85 90 95 100 
Staphylococcus aureus + + - - - - - - - - - - - - - - - - - - - - - 
Escherichia coli + + + + - - - - - - - - - - - - - - - - - - - 
Alcaligenes faecalis + + + + + + + + + + + - - - - - - - - - - - - 
Serratia marcescens + + + + + + + + - - - - - - - - - - - - - - - 
*Enterobacter aerogenes + + + + + + + + + + + + + + + + + + + + + - - 
*Klebsiella pneumoniae + + + + + + + + + + + + + + + + + - - - - - - 
Pseudomonas aeruginosa + + + + - - - - - - - - - - - - - - - - - - - 
Proteus vulgaris + + + + - - - - - - - - - - - - - - - - - - - 
     + growth of bacteria,  
- no growth of bacteria  
* least sensitive bacteria 
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Table 2: Effects of various concentrations of aqueous stem bark extract of Berlinia grandiflora against the pathogenic bacteria 
Pathogenic bacteria 
Final concentrations of aqueous stem bark extract in nutrient agar (mg/ml) 
20 21 22 23 24 25 30 35 40 45 47.5 50 55 60 65 70 75 80 85 90 95 
Staphylococcus aureus + - - - - - - - - - - - - - - - - - - - - 
Escherichia coli + + + + - - - - - - - - - - - - - - - - - 
Alcaligenes faecalis + + + + + + + + + + + - - - - - - - - - - 
*Serratia marcescens + + + + + + + + + + + + + + + + - - - - - 
*Enterobacter aerogenes + + + + + + + + + + + + + + + + + + + - - 
*Klebsiella pneumoniae + + + + + + + + + + + + + + + + - - - - - 
*Pseudomonas aeruginosa + + + + + + + + + + + + + + + - - - - - - 
Proteus vulgaris + + + + + + + + + + - - - - - - - - - - - 
 + growth of bacteria,  
- no growth of bacteria  
* least sensitive bacteria 
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Table 3: Effects of various concentrations of butanol stem bark extract of Berlinia grandiflora against the pathogenic bacteria 
Pathogenic bacteria 
Final concentrations of butanol stem bark extract in nutrient agar (mg/ml) 
21 22 23 24 25 30 35 40 45 47.5 50 55 60 65 70 75 80 85 90 95 100 140 150 160 200 
Staphylococcus aureus + - - - - - - - - - - - - - - - - - - - - - - - - 
*Escherichia coli + + + + + + + + + + + + + + + + + + + + - - - - - 
*Alcaligenes faecalis + + + + + + + + + + + + + + + + + + + + - - - - - 
*Serratia marcescens + + + + + + + + + + + + + + + + + + + + + - - - - 
*Enterobacter aerogenes + + + + + + + + + + + + + + + + + + + - - - - - - 
*Klebsiella pneumoniae + + + + + + + + + + + + + + + - - - - - - - - - - 
Pseudomonas aeruginosa + + - - - - - - - - - - - - - - - - - - - - - - - 
Proteus vulgaris + + - - - - - - - - - - - - - - - - - - - - - - - 
 + growth of bacteria,  
- no growth of bacteria  
* least sensitive bacteria 
 
Josephs et al. Afr. J. Pharmacol. Ther. 2012. 1(3): 92-96 
 
 
A KeSoBAP Publication ©2012. All rights reserved.  ISSN 2303-9841 
 
Table 4: Effects of various concentrations of butanol leaves extract of Berlinia grandiflora against the pathogenic bacteria 
Pathogenic bacteria 
Final concentrations of butanol leaves extract in nutrient agar (mg/ml) 
45 50 55 60 65 70 75 80 85 90 95 100 
Staphylococcus aureus + + - - - - - - - - - - 
Escherichia coli + - - - - - - - - - - - 
*Alcaligenes faecalis + + + + + + - - - - - - 
Serratia marcescens + + - - - - - - - - - - 
Enterobacter aerogenes + + - - - - - - - - - - 
Klebsiella pneumoniae + - - - - - - - - - - - 
Pseudomonas aeruginosa + - - - - - - - - - - - 
Proteus vulgaris + - - - - - - - - - - - 
 + growth of bacteria,  
- no growth of bacteria  
* least sensitive bacteria 
 
 
 
Josephs et al. Afr. J. Pharmacol. Ther. 2012. 1(3): 92-96 
 
 
A KeSoBAP Publication ©2012. All rights reserved.  ISSN 2303-9841 
 
Table 5: Effects of various concentrations of methanol stem bark extract of Berlinia grandiflora against the pathogenic bacteria 
Pathogenic bacteria 
Final  concentrations of butanol leaves extract in nutrient agar (mg/ml) 
45 50 55 60 65 70 75 80 85 90 95 100 
Staphylococcus aureus + + - - - - - - - - - - 
Escherichia coli + - - - - - - - - - - - 
*Alcaligenes faecalis + + + + + + - - - - - - 
Serratia marcescens + + - - - - - - - - - - 
Enterobacter aerogenes + + - - - - - - - - - - 
Klebsiella pneumoniae + - - - - - - - - - - - 
Pseudomonas aeruginosa + - - - - - - - - - - - 
Proteus vulgaris + - - - - - - - - - - - 
 + growth of bacteria,  
- no growth of bacteria  
* least sensitive bacteria 
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 Table 6: Effects of various concentrations of methanol leaves extract of Berlinia grandiflora against the pathogenic bacteria 
Pathogenic bacteria 
Final concentrations of methanol leaves extract in nutrient agar (mg/ml) 
45 50 55 60 65 70 75 80 85 90 95 100 
Staphylococcus aureus + + - - - - - - - - - - 
Escherichia coli + - - - - - - - - - - - 
*Alcaligenes faecalis + + + + + + - - - - - - 
Serratia marcescens + + - - - - - - - - - - 
Enterobacter aerogenes + + - - - - - - - - - - 
Klebsiella pneumoniae + - - - - - - - - - - - 
Pseudomonas aeruginosa + - - - - - - - - - - - 
Proteus vulgaris + - - - - - - - - - - - 
 + growth of bacteria,  
- no growth of bacteria  
* least sensitive bacteria 
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Table 7: Effects of various concentrations of ciprofloxacin hydrochloride against the pathogenic bacteria 
Pathogenic bacteria 
Final concentrations of ciprofloxacin in nutrient agar (µg/ml) 
5.0 7.5 10.0 15.0 20.0 25.0 30.0 
Staphylococcus aureus ++ + - - - - - 
Escherichia coli +++ ++ ++ + + - - 
*Alcaligenes faecalis +++ +++ +++ ++ ++ + - 
*Serratia marcescens +++ +++ ++ ++ ++ + - 
*Enterobacter aerogenes +++ ++ ++ ++ + + - 
*Klebsiella pneumoniae +++ +++ ++ ++ ++ + - 
Pseudomonas aeruginosa +++ ++ ++ + + - - 
Proteus vulgaris + - - - - - - 
 +++ heavy growth of bacteria 
  ++ moderate growth of bacteria 
    + minimal growth of bacteria 
    - no growth of bacteria  
    * least sensitive bacteria 
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